1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
631CE2169196083908525849D00036C8E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(FIELD%20Subject%20CONTAINS%20%22launch%22)%20AND%20(%22launch%22)%20and%20(field%20ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&ItemCatalog=BMR&SearchOrder=1&Start=11&Count=10
18
19OpenForm&Query=(FIELD%20Subject%20CONTAINS%20%22launch%22)%20AND%20(%22launch%22)%20and%20(field%20ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&ItemCatalog=BMR&SearchOrder=1&Start=11&Count=10
2018.204.227.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 11 - 20 of 24 Total Hits, Sorted by Relevance.

    |    

Winning Necessary Resources for a Successful Product LaunchDirect access to this research is not included with your membership level.

The objective of this benchmarking study is to help biopharma leaders develop competitive launch and pre-launch activity budgets to ensure successful U... (ID PSM-326)
Companies Profiled: Abbott, AbbVie, Amgen, Astellas, more ...

Best Practices in Launch Optimization: How Promotional Efficiency can be Leveraged to Support Multiple Products & IndicationsDirect access to this research is not included with your membership level.

In today’s marketplace, launching multiple products for a common therapeutic area is both resource-intensive and strategically challenging... (ID PSM-293)
Companies Profiled: Bayer Healthcare, Shionogi Inc., Roche Diagnostics, Mylan, more ...

Educating the Market to Support Successful Product Launches in OncologyDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

Click Download link on right for complimentary excerpt Aggressive market pressures challenge companies to rapidly deliver new products in the marke... (ID SM-190)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch SuccessDirect access to this research is not included with your membership level.

In this highly competitive and scrutinized marketplace, pharmaceutical and biotech companies have continuously examined the product launch process to cut costs and to increase performance... (ID PSM-230)
Companies Profiled: Medtronic, Sanofi-aventis, Organon, Teva Pharmaceutical Industries Ltd, more ...

Finding & Showcasing Digital Impact: ROI, Performance Metrics, Launch & Maximizing Digital PerformanceDirect access to this research is not included with your membership level.

In today’s tech-savvy consumer marketplace, digital marketing is no longer an optional component of a go-to-market strategy for healthcare companies... (ID PSM-327)
Companies Profiled: Abbott, Abbvie, Alcon, Astellas, more ...

Educating KOLs, Physicians, Patients and Payers to Support Successful Product LaunchesDirect access to this research is not included with your membership level.

The bio-pharmaceutical marketplace continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-248)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Success Factors and Failure Points in Metabolic Product LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the metabolic therapeutic area... (ID PSM-266)
Companies Profiled: GlaxoSmithKline, Bristol-Myers Squibb, Roche, Lilly, more ...

Success Factors and Failure Points in Cardiovascular Product LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the cardiovascular therapeutic area... (ID PSM-264)
Companies Profiled: GlaxoSmithKline, Bristol-Myers Squibb, Roche, Lilly, more ...

Educating the Marketplace to Support Successful Diabetes Product LaunchesDirect access to this research is not included with your membership level.

The bio-pharmaceutical marketplace – including the diabetes therapeutic area – continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-246)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Shaping the Marketplace to Support Successful Diabetes Product Launches: Tactics for Educating KOLs, Physicians, Patients and Payers Direct access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

The pharmaceutical, biotech and medical device marketplaces are rapidly changing due to new medicines, new technologies, new therapeutic approaches and a challenging regulatory environment... (ID SM-191)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...